Intraoperative management of recurrent leukoplakia at red zone

Oral leukoplakia (OL) is a potentially malignant oral disorder (PMOD) that sometimes trans-form into oral squamous cell carcinoma (OSCC). OL is one of the most frequent PMODs seen in the oral cavity. The global prevalence of OL is approximately 2.6%, with its worst prognosis of undergoing a malignan...

Full description

Saved in:
Bibliographic Details
Main Authors: S Elengkumaran (Author), C Deepak (Author), A Emmanuel Dhiravia Sargunam (Author), C Ravindran (Author), Sharada T Rajan (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5edc4fe68f0846a4aae90b05f0854dc1
042 |a dc 
100 1 0 |a S Elengkumaran  |e author 
700 1 0 |a C Deepak  |e author 
700 1 0 |a A Emmanuel Dhiravia Sargunam  |e author 
700 1 0 |a C Ravindran  |e author 
700 1 0 |a Sharada T Rajan  |e author 
245 0 0 |a Intraoperative management of recurrent leukoplakia at red zone 
260 |b Wolters Kluwer Medknow Publications,   |c 2021-01-01T00:00:00Z. 
500 |a 0975-7406 
500 |a 10.4103/jpbs.jpbs_183_21 
520 |a Oral leukoplakia (OL) is a potentially malignant oral disorder (PMOD) that sometimes trans-form into oral squamous cell carcinoma (OSCC). OL is one of the most frequent PMODs seen in the oral cavity. The global prevalence of OL is approximately 2.6%, with its worst prognosis of undergoing a malignant transformation. Leukoplakia is clinically divided into red zones (tongue and floor of mouth) and nonred zones (buccal mucosa, palate, and soft palate) areas. The red zone areas have more potency of transforming into malignancy. Hence, patients with red zone areas need to be followed up more frequently and treated appropriately. This case report signifies the importance of treating one such case of leukoplakia at red zone area. 
546 |a EN 
690 |a frozen sections 
690 |a oral squamous cell carcinoma 
690 |a potentially malignant disorder 
690 |a premalignant 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
690 |a Analytical chemistry 
690 |a QD71-142 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacy and Bioallied Sciences, Vol 13, Iss 6, Pp 1744-1746 (2021) 
787 0 |n http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2021;volume=13;issue=6;spage=1744;epage=1746;aulast=Elengkumaran 
787 0 |n https://doaj.org/toc/0975-7406 
856 4 1 |u https://doaj.org/article/5edc4fe68f0846a4aae90b05f0854dc1  |z Connect to this object online.